Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00850551 · ClinicalTrials.gov registry record · NA
Early Intervention in Pulmonary Exacerbation in Cystic Fibrosis
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT00850551 is a NA study that has completed, run by University of Washington. The registered enrollment target is 42 participants.
The verdict
NCT00850551, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
This study will be performed at the University of Washington. Forty subjects with Cystic Fibrosis will be enrolled, with 20 randomized into the usual care arm and 20 randomized into the intervention arm. All subjects will be enrolled for 6 months and have 3 study visits. One at baseline, midpoint, and final. The intervention arm subjects may have more study visits depending on their respiratory symptoms. The intervention arm subjects will perform home spirometry twice a week with a PiKo-6 hand held spirometer. They will also have a home-based telemonitoring system connected to their phone line. They will be prompted twice a week to answer questions regarding their health via the telemonitor. Subjects who are not able to utilize the home-based telemonitoring system will answer the questions regarding their health via the internet from their home computer. If the subject's spirometry falls by greater than 10% from baseline or the CF respiratory symptoms change in 3 or more of the 8 respiratory symptoms captured by the telemonitor questionnaire, the subject will be called by the research staff and clinically evaluated by the study PIs within three days. The usual care subjects will continue with their routine care at the University of Washington CF Clinic.
Interventions
- OTHER Early Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2009-01 |
| Est. Completion | 2011-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00850551
The ClinicalTrials.gov registry entry for NCT00850551 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Early Intervention is the first listed.
NCT00850551 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00850551 about?
NCT00850551 is a clinical study titled "Early Intervention in Pulmonary Exacerbation in Cystic Fibrosis". This study will be performed at the University of Washington. Forty subjects with Cystic Fibrosis will be enrolled, with 20 randomized into the usual care arm and 20 randomized into the intervention arm. All subjects will be enrolled for 6 months and have 3 study visits. One at baseline, midpoint, a...
What is the current status of trial NCT00850551?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2009-01. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00850551?
The interventions under investigation include: Early Intervention (OTHER).
Who is sponsoring clinical trial NCT00850551?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.